Alcayaga-Miranda Francisca, Cuenca Jimena, Luz-Crawford Patricia, Aguila-Díaz Carolina, Fernandez Ainoa, Figueroa Fernando E, Khoury Maroun
Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile.
Cells for Cells, Santiago, Chile.
Stem Cell Res Ther. 2015 Mar 17;6(1):32. doi: 10.1186/s13287-015-0013-5.
Stem cells isolated from menstrual fluid (MenSCs) exhibit mesenchymal stem cell (MSCs)-like properties including multi-lineage differentiation capacity. Besides, menstrual fluid has important advantages over other sources for the isolation of MSCs, including ease of access and repeated sampling in a noninvasive manner. Such attributes allow the rapid culture of MenSCs in numbers that are sufficient for therapeutical doses, at lower cell passages.
In this study, we advance the characterization of MenSC populations in comparison to bone marrow derived mesenchymal stem cells (BM-MSCs) with regards to proliferation, lineage differentiation, migration potential, secretion profile and angiogenic properties in vitro and in a matrigel plug assay in mice. We additionally tested their ability to support hematopoietic stem cell (HSC) expansion in vitro.
The phenotypic analysis of MenSCs revealed a profile largely similar to the BM-MSCs with the exception of a higher expression of the adhesion molecule CD49a (alpha1-integrin). Furthermore, the fibroblast colony forming units (CFU-F) from MenSCs yielded a 2 to 4 fold higher frequency of progenitors and their in vitro migration capacity was superior to BM-MSCs. In addition, MenSCs evidenced a superior paracrine response to hypoxic conditions as evidenced by the secretion of vascular endothelial growth factor and basic fibroblast growth factor and also improved angiogenic effect of conditioned media on endothelial cells. Furthermore, MenSCs were able to induce angiogenesis in a matrigel plug assay in vivo. Thus, an 8-fold increase in hemoglobin content was observed in implanted plugs containing MenSCs compared to BM-MSCs. Finally, we demonstrated, for the first time, the capacity of MenSCs to support the ex-vivo expansion of HSCs, since higher expansion rates of the CD34+CD133+ population as well as higher numbers of early progenitor (CFU-GEMM) colonies were observed in comparison to the BM source.
We present evidence showing superiority of MenSCs with respect to several functional aspects, in comparison with BM-MSCs. However, the impact of such properties in their use as adult-derived stem cells for regenerative3 medicine remains to be clarified.
从月经液中分离出的干细胞(MenSCs)具有间充质干细胞(MSCs)样特性,包括多向分化能力。此外,与其他用于分离MSCs的来源相比,月经液具有重要优势,如易于获取且能以非侵入性方式重复采样。这些特性使得MenSCs能够在较低细胞传代次数下快速培养出足够用于治疗剂量的细胞数量。
在本研究中,我们将MenSC群体与骨髓来源的间充质干细胞(BM-MSCs)进行比较,在体外以及小鼠基质胶栓试验中,对它们的增殖、谱系分化、迁移潜力、分泌谱和血管生成特性进行了表征。我们还测试了它们在体外支持造血干细胞(HSC)扩增的能力。
MenSCs的表型分析显示,其特征与BM-MSCs基本相似,但黏附分子CD49a(α1整合素)的表达较高。此外,MenSCs的成纤维细胞集落形成单位(CFU-F)产生祖细胞的频率高出2至4倍,其体外迁移能力优于BM-MSCs。另外,MenSCs在低氧条件下表现出更强的旁分泌反应,这可通过血管内皮生长因子和碱性成纤维细胞生长因子的分泌得以证明,同时条件培养基对内皮细胞的血管生成作用也有所增强。此外,MenSCs能够在体内基质胶栓试验中诱导血管生成。因此,与BM-MSCs相比,含有MenSCs的植入栓中血红蛋白含量增加了8倍。最后,我们首次证明了MenSCs支持HSCs体外扩增的能力,因为与BM来源相比,观察到CD34+CD133+群体的扩增率更高,早期祖细胞(CFU-GEMM)集落数量也更多。
我们提供的证据表明,与BM-MSCs相比,MenSCs在多个功能方面具有优势。然而,这些特性在其作为成人来源的干细胞用于再生医学中的影响仍有待阐明。